Nystagmus in children with primary brain tumours in Denmark between 2007 and 2017

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 524 KB, PDF-dokument

Background
The aim of the study was to evaluate the prevalence, clinical characteristics, and diagnostic importance of nystagmus in children with brain tumours.

Methods
A nation-wide retrospective review of all children diagnosed with a brain tumour between January the 1st, 2007 and December 31st, 2017, in Denmark. Data is based on information from the Danish Childhood Cancer Registry, hospital records from paediatric- and ophthalmological departments, and records from private ophthalmologists.

Results
Nystagmus was observed in 13.7% (60/437) of children with a brain tumour. In 50/60 children (83.3%) nystagmus was an incidental finding at the clinical examination and only in 10/60 children (16,7%) were nystagmus noticed by patient/caregivers prior to the clinical examination. In 38/60 children nystagmus was observed before the brain tumour diagnosis, most often (16/38, 42%) the same day as the diagnosis was made. In 22/60 children nystagmus was found after the brain tumour diagnosis (prior to any treatment) with a median of four days (range 0-47) after the brain tumour diagnosis. Nystagmus was most commonly binocular (56/60, 93.3%) and gaze-evoked (43/60, 71.7%). The median number of additional symptoms and/or clinical findings was five (range 0–11).

Conclusion
Nystagmus is frequent in children with brain tumours and is typically accompanied by other symptoms and clinical signs. However, nystagmus is often first recognized by the ophthalmologist late in the time course. Therefore, raising awareness of the importance of looking for nystagmus in children with unspecific neurological symptoms might contribute to increased suspicion of brain tumour and thereby faster diagnosis.
OriginalsprogEngelsk
TidsskriftEye (Basingstoke)
Vol/bind38
Udgave nummer4
Sider (fra-til)766-772
Antal sider7
ISSN0950-222X
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
The study was supported by Engineer Otto Christensen’s Foundation, The Synoptik Foundation, Doctor Emil Sofus Friis and wife Olga Doris Friis’s Foundation, the nation-wide research program Childhood Oncology Network Targeting Research, Organisation & Life expectancy (CONTROL), supported by the Danish Cancer Society (R-257-A14720) and the Danish Childhood Cancer Foundation (2019-5934 and 2020-5769). The supporting foundations had no role in the design or conduct of this research.

Publisher Copyright:
© The Author(s) 2023.

ID: 385135641